Lymph Node Harvest in Esophageal Cancer After Neoadjuvant Chemoradiotherapy

Pathologic Nonresponders after Neoadjuvant Chemoradiation for Esophageal Cancer Demonstrate no Survival Benefit Compared with Patients Treated with Primary Esophagectomy

(2011) George W. Dittrick et al.   ANNALS OF SURGICAL ONCOLOGY

Cancer statistics, 2011

(2011) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Improved survival in patients with lymph node-positive gastric cancer who received preoperative radiation

(2011) Ravi Shridhar et al.   CANCER

Challenging the Feasibility and Clinical Significance of Current Guidelines on Lymph Node Examination in Rectal Cancer in the Era of Neoadjuvant Therapy

(2011) Anand Govindarajan et al.   JOURNAL OF CLINICAL ONCOLOGY

The total number of resected lymph node is not a prognostic factor for recurrence in esophageal squamous cell carcinoma patients undergone transthoracic esophagectomy

(2011) Po-Kuei Hsu et al.   JOURNAL OF SURGICAL ONCOLOGY

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis

(2011) Katrin M Sjoquist et al.   LANCET ONCOLOGY

Pathologic Response after Neoadjuvant Therapy is the Major Determinant of Survival in Patients with Esophageal Cancer

(2010) Kenneth L. Meredith et al.   ANNALS OF SURGICAL ONCOLOGY

Optimum Lymphadenectomy for Esophageal Cancer

(2009) Nabil P. Rizk et al.   ANNALS OF SURGERY

Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03

(2009) Mark S. Roh et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer

(2008) Alexander J. Greenstein et al.   CANCER